CP-105,696

CAS : 158081-99-3

Ref. 3D-IGA08199

Informations sur le produit

• Nom: CP-105,696
• Synonymes: 1-[(3S,4R)-3-([1,1′-Biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]cyclopentanecarboxylic acid, Cp 105696, Cyclopentanecarboxylic acid, 1-[(3S,4R)-3-([1,1′-biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-, Cyclopentanecarboxylic acid, 1-[3-([1,1′-biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-, (3S-trans)-, Cyclopentanecarboxylicacid, 1-[3-([1,1'-biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-,(3S-trans)-, Pfizer 105696

Description

CP-105,696 is a monoclonal antibody that binds to the chemoattractant protein (CXCL12) and blocks its activity. CP-105,696 has been shown to inhibit the growth of cancer cells in vitro and in vivo by binding to CXCR4, a receptor for CXCL12. It is also used for the treatment of inflammatory bowel disease and other autoimmune diseases. CP-105,696 inhibits inflammatory responses by blocking the release of proinflammatory cytokines IL-1β and TNFα from activated macrophages. The drug binds to a region on the chemokine that is involved in cell signaling, preventing it from interacting with its receptor. CP-105,696 also inhibits angiogenesis by inhibiting vascular endothelial growth factor (VEGF).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 428.52 g/mol
• Formule: C₂₈H₂₈O₄
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder